Match Document Document Title
DE102008028357A1 New Hybrid System for Brassica napus  
The present invention relates to a conditional kerngenisch inherited Male sterility system in Brassica napus. Embodiments of the present invention provide the (Male sterile) female line precursor...
DE102007035730A1 Determining linezolid-resistance in microorganism comprises contacting microorganism with oligonucleotide-probe that can bind to microorganism ribosomal RNA showing point mutation caused by linezolid-resistance and detecting microorganism  
Determination of linezolid-resistance in microorganisms present in a sample, comprises contacting the sample with at least an oligonucleotide-probe, which can bind under hybridization conditions...
DE102007035250A1 A method for separating non-proteinaceous biomolecules, in particular nucleic acids from protein-containing samples  
The This invention relates to a process for isolating non-proteinaceous biomolecules, in particular nucleic acids, wherein on a solid phase, a protein degradation is carried out.
DE102007032799A1 New sugar-containing polypyridine metal complexes e.g. useful as fluorescence markers in biological systems or for treating abnormal cells  
Sugar-containing polypyridine metal complexes (I) are new. Sugar-containing polypyridine metal complexes of formula (I) are new. (L1 n)(L2 m)(L3 o)(L4 p)(L5 q)M (I) L1-L5 : ligands, at least one...
DE60224401T2 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH HETEROBICYLISCHER STRUCTURE  
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein: A is O, S, N R 1 , or C R 1 , wherein R 1 is defined herein; ----- represents either a single...
DE10319917B4 Process for the selective carbohydrate oxidation using a supported gold catalysts  
process for the selective oxidation of carbohydrates, carbohydrate blend or composition containing the same, wherein an aqueous solution of Carbohydrate, the mixture or composition in the presence...
DE102007028030A1 Biosurfactants and their preparation  
The Invention relates to a process for Biotensidherstellung wherein biotensiderzeugende microorganisms in a growing medium be moved. It is provided that the growing medium used in excess and a...
DE60224400T2 HEPATITIS C VIRUS POLYMERASE INHIBITORS WITH HETEROBICYLISCHER STRUCTURE  
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I: wherein: A is O, S, N R 1 , or C R 1 , wherein R 1 is defined herein; ----- represents either a single...
DE19730408B4 Composition for topical application  
composition for external use with at least one particulate material selected is selected from the group (A) of the ellagic acid-based compound of the general formula (I): where R1. R2, R3 and R4...
DE102007053947A1 A process for the synthesis of sucrose-6-acetic acid ester  
The This invention discloses a method for the synthesis of sucrose-6-acetic acid esters, comprising the steps of: adding sucrose in a polar, aprotic solvent and stirring the solvent, to solve...
DE102006035392A1 Prognostic markers for predicting the five-year progression-free survival of patients with colon cancer based on expression profiles of biological samples  
The Invention relates to the use of gene expression profiles for Prediction of the five-year progression-or relapse-free survival of patients undergoing colorectal a was removed carcinoma in UICC...
DE102007016367A1 Polymorph of Clarithromycin (Form V)  
The Invention relates to a polymorphic form of clarithromycin (form V), their preparation and use.
DE102007015775A1 A method for detecting Paratuberkolose  
The This invention relates to a method for specifically and sensitive detection of Mycobacterium avium ssp. paratuberculosis (MAP). In fecal, tissue and organ samples using a real-time PCR methods
DE102006050091A1 Process for the selective localization of active ingredients to and in mitochondria and corresponding active ingredients  
The This invention relates to novel processes for the selective localization of active ingredients both at and in mitochondria within living cells and agents that through without further aids...
DE102007010252A1 Set of control genes for normalizing gene expression data from blood samples comprises seven RNA sequences  
Set of control genes for normalizing gene expression data from blood samples comprises seven RNA sequences corresponding to GenBank accession numbers NM001562, NM001228, NM001993, NM002209,...
DE102007010311A1 Organism-specific hybridizable nucleic acid molecule  
The This invention relates to a method for producing a organism-specific hybridizable nucleic acid molecule, a product made by this method nucleic acid molecule, a kit which comprises at least one...
DE102007009073A1 Crosslinked poly(meth)acrylic acid cation exchanger, e.g. for water treatment, is obtained by polymerizing pearl-form monomer drops while supplying monomers, crosslinker and optionally initiator  
Production of crosslinked poly(meth)acrylic acid type cation exchangers (I) involves polymerizing pearl-form monomer drops in a (preferably aqueous) continuous phase, while supplying a mixture of...
DE102007007644A1 New aminocoumarin compounds, designated novclobiocins, useful as broad-spectrum antibiotics and cytotoxic agents, prepared sing genetically modified bacterial strains  
New aminocoumarin compounds (I), designated novclobiocins, consist of clorobiocin analogs containing modified N-acyl residues and/or 8-substituents. Aminocoumarin compounds of formula (I) are new....
DE102007007738A1 Color-coded oligosaccharides or polysaccharides  
The Invention relates to color-marked oligosaccharides or polysaccharides, process for producing these color-marked oligosaccharides or polysaccharides and their use for kidney function determination.
DE102005047736B4 Method and system for isolating nucleic acids from any complex starting materials  
systems without chaotropic and antichaotropic components for isolating nucleic acids from nucleic acids containing materials comprising • at least a per se known Buffer for proteolytic digestion...
DE102007005804A1 Secreted luciferase Lu164M3 and their use  
The Invention relates to the nucleotide and amino acid sequence and the type and use of Lu164M3 and the Use of secreted luciferases.
DE102007005803A1 Secreted luciferase MLuc7 and their use  
The Invention relates to the nucleotide and amino acid sequence and the type and use of the secreted luciferase MLuc7.
DE102007005655A1 Apparatus and method for purification of nucleic acids  
disclosed A device for purification of nucleic acids by negative chromatography comprising a hollow body each having an opening at the upper and at the lower end, which includes a stationary solid...
DE102005011003B4 Method and means for the differential diagnosis of thyroid tumors  
process for the differential diagnosis of thyroid tumors to differentiate of benign tumors to malicious Tumors wherein: 1) RNA is isolated from a tissue sample of the thyroid gland, 2.) in the...
DE102007027201A1 Conjugates useful for chemotherapy or positron emission tomography comprising a platinum complex and a glucose compound  
Conjugates comprising a chemotherapy-active platinum complex and a glucose compound, optionally linked together via a spacer, are new. ACTIVITY : Cytostatic. No biological data given. MECHANISM OF...
DE102007002386A1 Pharmaceutically active compounds  
The present invention relates to pharmaceutically active compounds from an isoflavone or isoflavone glycoside and covalently with this connected, an amino acid, a peptide or peptide derivative...
DE10085149B4 A process for preparing acarbose with high purity  
process for producing highly pure acarbose with an acarbose content of at least 98%, comprising the steps of: Filtering a acarbose containing fermentation culture, Adjusting the pH of the Filtrate...
DE102006059095A1 Microarray for detecting viruses is divided into fields, each bearing a nucleic acid probe capable of detecting a specific herpes virus  
Microarray for detecting viruses is divided into fields, each bearing a nucleic acid probe capable of detecting a specific virus, namely a herpes simplex virus probe, a varicella zoster virus...
DE102006054233A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE102006054213A1 Homogeneous phase acetalation of oligo- or polysaccharide, e.g. for production of acid-crosslinkable cellulose acetals, by reaction with vinyl ether in solution in ionic liquid  
Acetalation of di-, oligo- or polysaccharides (or their derivatives) (I) is carried out by dissolving (I) in at least one ionic liquid (II) and reacting with a vinyl ether (III). Independent...
DE102006054202A1 Alleles of oxyR gene from corynebacteria  
The Invention relates to mutants and alleles of the gene of coryneform oxyR Bacteria coding for Variants of the OxyR-transcriptional regulator, and methods for preparing of amino acids by using...
DE102007045173A1 Nucleotide analogs useful for nucleic acid synthesis or sequencing comprise a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker  
Nucleotide analogs (I) comprising a nucleotide component, a sterically demanding macromolecular ligand, a label and a linker are new. Independent claims are also included for: (1) nucleic acid...
DE102006053690A1 New anionic cyclopentadienyl-carbohydrate compounds useful in the preparation of metallocene-carbohydrate compound, which is useful to treat cancer  
Anionic cyclopentadienyl-carbohydrate compounds (I), are new. Anionic cyclopentadienyl-carbohydrate compounds of formula (I), are new. m : 0-10 (preferably 1); ER1 : OH, alkoxy, nucleo-base or...
DE102006053637A1 New fluorine-substituted 1,4-benzothiepine-1,1-dioxide, a process for their production, medicaments containing these compounds and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The compounds are suitable for. B. as hypolipidemic agents.
DE102006053635A1 New substituted with benzyl 1,4-Benzothiepin-1,1-dioxide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use  
The Invention relates to the compounds of formula I and physiologically acceptable Salts. The connection is suitable for. B. as hypolipidemic agents.
DE102006053385A1 Enterococcus faecalis and / or Enterococcus faecium antigen  
The This invention relates generally to the field of detection and prevention of infectious diseases caused by Enterococcus faecalis and / or Enterococcus faecium caused. In particular relates to...
DE102006035393A1 Prognostic markers for the classification of the three-year progessionsfreien survival of patients with colon cancer based on expression profiles of biological samples  
The Invention relates to the use of gene expression profiles for Predicting the three-year progression-free survival or recurrence of patients receiving colorectal cancer in UICC stage I or II was...
DE202005021489U1 A composition as for the synthesis of compounds phosphitylated  
Composition, containing a compound capable of forming enolates, and a phosphoramidite.
DE202005021488U1 Mixture of an activator and an additive for preparing phosphitylated compounds  
A Mixture of an activator having the formula I wherein R = alkyl, cycloalkyl, Aryl, aralkyl, heteroalkyl, heteroaryl R1. R2 = Either hydrogen or together form a 5- or 6-membered ring X1, X2 =...
DE112004002408B4 A process for obtaining an enriched population of siRNA-expressing cells  
process for obtaining cells which are capable of inhibiting RNA expressing, said method comprising: introducing at least one nucleic acid in a cell, wherein the at least one nucleic acid in the...
DE102006049821A1 New, well tolerated metal chelates, for use as radiodiagnostic, radiotherapeutic or NMR and X-ray diagnostic agents, contain chelator and perfluorinated polyethylene glycol residues  
New metal chelates (I) (optionally in salt form) contain (a) perfluorinated polyethylene glycol (PEG) residue(s), (b) chelator residue(s) and (c) at least one equivalent of metal(s) of atomic...
DE10226203B4 Condensed palatinose, processes for their preparation and their use  
process for producing condensed palatinose from palatinose by Melt, Palatinose a solution of a catalytically active acidic Substance added to water, the water in the obtained mixture is present in...
DE102007016151A1 coated implant  
implant with a coating, wherein the implant is an amino-functionalized Parylene, an oligonucleotide and / or an oligopeptide comprising, which have a specific binding affinity for CD 34-positive...
DE102006042891A1 Breaking down of poly-, oligo-, disaccharide or its derivatives, useful as raw material e.g. in textile industry, comprises dissolving the derivatives in an ionic liquid and treating the mixture at an elevated temperature  
Method for breaking down of poly-, oligo-, disaccharide (I) or its derivative comprises dissolving (I) in an ionic liquid and treating the mixture at an elevated temperature, optionally in the...
DE102006042890A1 Silylating poly-, oligo-, disaccharides derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent  
Silylating poly-, oligo-, disaccharides or their derivatives comprises dissolving the poly-, oligo- disaccharides in an ionic liquid and reacting the obtained mixture with a silylating agent. An...
DE102006037786A1 Nucleosides, containing these drugs and their use  
The Invention relates to specific nucleosides, and drugs which these nucleosides contained. Furthermore, the invention relates to the Use of such nucleosides for the preparation of a medicament,...
DE102006039479A1 Programmable oligonucleotide  
The Invention relates to methods and apparatus for the preparation of synthetic nucleic acids.
DE10066210B4 Use of perfluoroalkyl-metal complexes as contrast agents in MR imaging for displaying plaques  
use of perfluoroalkyl-metal complexes that a critical micelle concentration <10-3 minor, a hydrodynamic micelle diameter> 1 nm and a proton relaxivity in plasma> 10 l / mmol · s, as contrast...
DE102007007750A1 avermectin  
New Avermectin derivatives of the formula (I), in which -C22R1-AC23R2. R3, R4 and R5 the meanings indicated in the description have,Methods for preparing these substances and their use for...
DE102006037580A1 Sandel Perfume receptors  
The Invention relates to the field of olfactory receptors, the receptive influencing Medications and biosensors. The invention further relates to compounds of the general formula (I), in whichX...